1. Home
  2. CLST vs IXHL Comparison

CLST vs IXHL Comparison

Compare CLST & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Bancorp Inc.

CLST

Catalyst Bancorp Inc.

N/A

Current Price

$15.04

Market Cap

54.6M

Sector

N/A

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.42

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLST
IXHL
Founded
1922
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
54.6M
49.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CLST
IXHL
Price
$15.04
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.1K
24.0M
Earning Date
01-22-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.60
N/A
Revenue
$11,340,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$25.20
N/A
Revenue Growth
133.67
N/A
52 Week Low
$10.67
$0.08
52 Week High
$15.30
$2.25

Technical Indicators

Market Signals
Indicator
CLST
IXHL
Relative Strength Index (RSI) 68.00 55.34
Support Level $15.00 $0.35
Resistance Level $15.05 $0.50
Average True Range (ATR) 0.07 0.04
MACD -0.05 0.01
Stochastic Oscillator 96.87 59.53

Price Performance

Historical Comparison
CLST
IXHL

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: